57732-63-5

Basic information

• Product Name: Z-Glu(OMe)-OtBu
• Synonyms: Z-Glu(OMe)-OtBu
• CAS NO: 57732-63-5
• Molecular Formula: C₁₈H₂₅NO₆
• Molecular Weight: 351.39
• Mol File: 57732-63-5.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Z-Glu(OMe)-OtBu(CAS DataBase Reference)
• NIST Chemistry Reference: Z-Glu(OMe)-OtBu(57732-63-5)
• EPA Substance Registry System: Z-Glu(OMe)-OtBu(57732-63-5)

Safety Data

• Hazardous Substances Data: 57732-63-5(Hazardous Substances Data)

Usage

Description

Z-Glu(OMe)-OtBu is a chemical compound that consists of Z-Glu, OMe, and OtBu. Z-Glu serves as a protecting group for the carboxyl group, OMe represents the methoxy group, and OtBu denotes the tert-butyloxycarbonyl group. Z-Glu(OMe)-OtBu plays a crucial role in organic synthesis, particularly in the field of peptide synthesis, where it is utilized to protect specific functional groups and regulate the reactivity of amino acids.

Uses

Used in Organic Synthesis:
Z-Glu(OMe)-OtBu is used as a reagent in organic synthesis for its ability to protect certain functional groups and control the reactivity of amino acids. This makes it a valuable tool in the creation of peptide bonds and the synthesis of complex peptides and proteins.
Used in Peptide Synthesis:
In the field of peptide synthesis, Z-Glu(OMe)-OtBu is employed as a protecting group for the carboxyl group of amino acids. This protection is essential for preventing unwanted side reactions during the synthesis process, ensuring the successful formation of the desired peptide bonds and the accurate assembly of complex peptides and proteins.

Upstream product

• 4652-65-7 (S)-2-Benzyloxycarbonylamino-pentanedioic acid 5-methyl ester 
• 115-11-7 isobutene 
• 75-65-0 tert-butyl alcohol 
• 5891-45-2 (S)-2-(benzyloxycarbonylamino)pentanedioic acid tert-butyl ester 
• 74-88-4 methyl iodide 
• 540-88-5 acetic acid tert-butyl ester 
• 501-53-1 benzyl chloroformate 
• 35418-16-7 L-t-butyl pyroglutamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 3077-51-8 γ-methyl L-glutamate hydrochloride 
• 4124-76-9 N-(benzyloxycarbonyl)-L-glutamic acid anhydride 
• 32159-21-0 Cbz-L-pGlu-OH 
• 1499-55-4 L-glutamic acid 5-methyl ester 
• 56-86-0 L-glutamic acid 

Downstream Products

• 5891-45-2 (S)-2-(benzyloxycarbonylamino)pentanedioic acid tert-butyl ester 
• 79640-72-5 L-glutamic acid 1-tert-butyl ester 5-methyl ester 
• 81470-51-1 tert-butyl N-benzyloxycarbonyl-L-pyroglutamate 
• 170465-55-1 2-tert-butyl 4-methyl (2S)-1-benzyloxycarbonyl-5-methyl-2,3-dihydro-1H-pyrrole-2,4-dicarboxylate 
• 223468-19-7 N-Hydroxy-2-(pyridin-3-yl)methyl-4-(2-phenylethylcarbamoyl)-4-[N-(4-phenoxyphenylcarbonyl)amino]butyramide 
• 124620-51-5 (S)-tert-butyl 2-(((benzyloxy)carbonyl)amino)-5-hydroxypentanoate 
• 130761-69-2 1-tert-butyl-N²-(3,5-dinitrobenzoyl)-L-glutamic acid 5-methyl ester 
• 149838-33-5 3-phenoxymethyl>-5-(((tert-butoxycarbonyl)amino)methyl)furan, tetra-tert-butyl ester 
• 149838-34-6 3-phenoxymethyl>-5-(((tert-butoxycarbonyl)amino)methyl)furan, tri-tert-butyl ester 
• 149838-35-7 3-phenoxymethyl>-5-(((tert-butoxycarbonyl)amino)methyl)furan, di-tert-butyl ester 

Relevant articles and documents

SERINE REPLACEMENT POLYMYXIN ANALOGUES USEFUL AS ANTIBIOTIC POTENTIATORS

The disclosure provides compounds of the formula I or a tautomer thereof, or a pharmaceutically acceptable salt of either of the foregoing. The variables R1 and R2 are defined in the disclosure. The disclosure further includes pharmaceutical compositions comprising a compound of formula I together with at least one pharmaceutically acceptable carrier. The disclosure also includes a method of sensitizing bacteria to an antibacterial agent, comprising administering a therapeutically effective amount of the antibacterial agent and a compound of formula I to a patient infected with the bacteria, simultaneously or sequentially.

LYSINE ISOTOPOLOGUES, COMPOSITIONS COMPRISING THE SAME AND METHODS OF SYNTHESIS

This invention relates to lysine isotopologues of Formulas I and 1-A, as described herein, and processes for synthesizing the same and derivatives and intermediates involved therein. In one aspect, described herein is a chemical compound comprising an isotopically labeled analog, i.e., an isotopologue of a standard or naturally occurring lysine. The lysine isotopologue is synthetically formed to have stable isotopes of elements incorporated at selected positions. As such, the lysine isotopologue has a molecular mass different from the mass of a standard or naturally occurring lysine.

ACE-INHIBITORS HAVING ANTIOXIDANT AND NO-DONOR ACTIVITY

Multifonctional ACE inhibitor compounds are provided, that combine ACE-inhibiting activity with capability to scavenge superoxide and other reactive oxygen species, and that may further function as nitric oxide donors. The compounds are useful for preventing or treating various disorders, including cardiovascular, and diabetes associated disorders.